Sonoma Biotherapeutics

Sonoma Biotherapeutics

Biotechnology, 400 E Jamie Ct Ste 250, South San Francisco, California, 94080, United States, 51-200 Employees

sonomabio.com

  • twitter
  • LinkedIn

phone no Phone Number: 41********

Who is SONOMA BIOTHERAPEUTICS

Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by ...

Read More

map
  • 400 E Jamie Ct Ste 250, South San Francisco, California, 94080, United States Headquarters: 400 E Jamie Ct Ste 250, South San Francisco, California, 94080, United States
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $1 Million to $5 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 8733

checked-icon Does something look wrong? Fix it. | View contact records from SONOMA BIOTHERAPEUTICS

Sonoma Biotherapeutics Org Chart and Mapping

Employees

Mindy Jensen

Director, Patient Operations

Claire Crowther

Associate Director, Program Management

Brian Crawford

Senior Director Corporate Communications

Brenna Boone

People & Culture Coordinator

Peter Kegler

Senior Associate Scientist

Gauri Deorkar

Associate Scientist, Process Development

Aditi Makhija

Senior Associate Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Sonoma Biotherapeutics

Answer: Sonoma Biotherapeutics's headquarters are located at 400 E Jamie Ct Ste 250, South San Francisco, California, 94080, United States

Answer: Sonoma Biotherapeutics's phone number is 41********

Answer: Sonoma Biotherapeutics's official website is https://sonomabio.com

Answer: Sonoma Biotherapeutics's revenue is $1 Million to $5 Million

Answer: Sonoma Biotherapeutics's SIC: 8733

Answer: Sonoma Biotherapeutics has 51-200 employees

Answer: Sonoma Biotherapeutics is in Biotechnology

Answer: Sonoma Biotherapeutics contact info: Phone number: 41******** Website: https://sonomabio.com

Answer: Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access